Search Results for: gantenerumab

Gantenerumab

Gantenerumab (RG1450, RO4909832) is an investigational immunotherapy being developed to treat Alzheimer’s disease by potentially reducing beta-amyloid plaques in the brain. Gantenerumab was developed originally by Chugai Pharmaceuticals, which is ... Read more